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Fondazione Don C.Gnocchi, IRCCS, via Imprunetana124, 50020, Pozzolatico, Firenze, Italy.Quality of Life (QoL) varies with severity of the disease
in patients with chronic obstructive pulmonary disease
(COPD) as assessed in terms of FEVI%pv. Speci¢c mea-
sures of QoL, e.g. S.George Respiratory Questionnaire
(SGRQ)(l) progressively deteriorate with increase in the
disease severity from stages I to III (2). Contrary to ex-
pectations, even patients with mild disease exhibited
substantial compromise in QoL. Also, the di¡erence in
SGRQ scores between patients without co-morbid and
with co-morbid conditions were evident mostly in stage
I disease andmuch less in stages II and III. In general, how-
ever, the coe⁄cient of relationship between FEVI and
SGRQ scores ranged from 0?2 to 0?4with amild increase
being evident in patients without no co-morbidity,(2).
In a multivariate analysis, FEVI and to a lesser extent
well-being scores were found to be the most signi¢cant
independent predictors of survival in COPD (3). By ap-
plying factor analysis Wegner et al. (4) were able to ¢nd
that QoL along with BDI and 6mWD were loading
variables on symptom factor while both obstruction
and hyperin£ation identi¢ed other factors which
independently characterized the clinical conditions of
COPD patients.
In a contemporaneous studyTsukino et al. (5) individu-
ated three di¡erent de¢ned factors: air£ow limitation,
di¡using lung capacity (DLCO) and vital capacity. They
noticed a mild level of relationship between factors and
components of CRQ questionnaire (6). In the same study
the logistic regression indicated that an increase in FEVI
of 10% reduced the risk of having disturbances in the
dyspnoea dimension of CRQ by 31% and the mastery
dimension by 41%. Also, an increase in DLCO reduced
the risk of the dimension of fatigue by 18% and smoking
habits increased the risk of both dyspnoea and fatigue.Received 4 December 2001and accepted 20 December 2001.
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Fax: +39 55 2601257; E-mail: riabri¢@tin.igNonetheless, a longitudinal study (7) indicated that
changes in dyspnoea, airway obstruction and health sta-
tus provided independent but complementary informa-
tion about the conditions of COPD. In that study (7)
improvement in transitional dyspnoea index (TDI) focal
score was associated with a variable increase in physical
functioning ,health perception, role and social function-
ing components of Medical Outcomes Study (MOS), and
decrease in mental health and pain components.
Similarly, a unit increase in FEVI improved almost all the
components.
In a1yr survey study Seemungal et al. (8) reported the
association of SGRQ total score with exacerbation fre-
quency, MRC and daily wheezing. The latter, along with
past exacerbation, predicted the frequency of exacerba-
tions (8). Thus the relationship between the healthy
status with frequency of exacerbations contributes to
individuate patients at risk of exacerbations and
disability.
Reports obtained in selectedpatientswho underwent
lung volume reduction surgery (LVRS) have shown good
associations between changes in exercise capacity and
some dimensions of generic measures of QoL (9). The
study also shows that 6mWTand exercise capacitymea-
sure di¡erent outcomes, with the ¢rst assessing social
activity and the second assessing physical performance.
A signi¢cantrelationshipbetween improvedgeneral sick-
ness impact pro¢le (SIP) scores and change in O2 cost of
breathing from baseline to maximal work load after 3
months LVRS has been recently reported by Leyenson
et al. (10) and byYousen (11). In a long-term follow up (12)
the SIP scores were lower at 3 months and were
sustained, in associationwith an improved in forced vital
capacity.
Pulmonary rehabilitation programs (PRP) improved
the physical performance and disease speci¢c measures
in three groups of patients with mild, moderate and
severe COPD (13). Importantly, there were similar
improvements inmaximumworkcapacity andmaximum
374 RESPIRATORYMEDICINEoxygen uptake at each stage of COPD accompanied by
improvements in physical function and QoL (13). The
studyby Foglio etal. (14) shows that PRPmaybe e¡ective
on SGRQ: with an e¡ect lasting longer than that on ex-
ercise capacity (6mWT). Importantly, the group of im-
provers and non improvers to PRP did di¡er in terms of
baseline SGRQ total scores and baseline dyspnoea index
(BDI) but not in pulmonary function.On the other hand,
improvement in QoL as assessed by disease generic
questionnaires (SF-36) appears not to be associatedwith
amelioration of functional capacity (15). Furthermore, in
patients with severe emphysema, therewas no relation-
ship between changes in FEV1 and changes in the scores
of a generic questionnaire of QoL (SF-36) after PRP, and
onlypartial after LVRS (16). In contrast, the association of
both treatments was characterized by positive even if
weak relationships between changes in FEV1and changes
in the domains of physical functioning, social functioning
and vitality of SF-36 (16).
It has been recently shown that there are not signi¢-
cant di¡erences between SGRQ and chronic respiratory
questionnaire (CRQ) in their correlations with physiolo-
gical parameters, exercise capacity and assessment of
dyspnoea (17).
Finally, not in linewith a previous study carried out by
applying generic questionnaires of QoL (18), Sanchez
et al. (19) have found that targeted inspiratory muscle
training 6 days a week for 6 months improves each cate-
gory of CRQ, relieves dyspnoea and increases the capa-
city towalk at 6 months.
In turn, given the weakness of the relationships
between health related quality of life (HRQL) measures
and functional data (20^23), a message is clear: for
patients with COPD measures of QoL provide informa-
tion above andbeyond that providedbymeasures of lung
function or exerciseperformance.Thus,QoL assessment
should be an integral part of the conduct and interpreta-
tion of clinical studies (11).
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